Vicore Pharma Holding AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was SEK 111.89 million compared to SEK 60.7 million a year ago. Basic loss per share from continuing operations was SEK 1 compared to SEK 0.83 a year ago.